Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

George Oliveira

Vascular & Interventional Radiology Miami, FL Medical Doctor

NPI 1285895318 CMS profile 1112558

8900 N Kendall Dr, Miami, FL 33176

Open in the dashboard

General payments

$666,054

392 records reported · program years 2019–2025

Research payments

$201,485

Paid to them · 33 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,448,609 paid to institutions, not to them · program years 2019–2025

Through program year 2025, George Oliveira of Miami, FL is reported in the CMS Open Payments database as having received $666,054 across 392 general payments and $201,485 in research payments paid to them. Separately, studies naming them as principal investigator received $2,448,609 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $83,137 20
2024 General $5,360 16
2024 Research $46,653 8
2023 General $15,985 17
2023 Research $53,110 3
2022 General $23,335 12
2022 Research $18,585 2
2021 General $267,101 164
2020 General $231,997 130
2019 General $122,276 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Oliveira
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to George Oliveira were reported at $0. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year George Oliveira Vascular & Interventional Radiology median Middle half National median
2019 $122,276 $422 $125–$1,555 $163
2020 $231,997 $200 $68–$652 $114
2021 $267,101 $280 $99–$866 $132
2022 $23,335 $433 $137–$1,497 $149
2023 $15,985 $506 $152–$2,019 $160
2024 $5,360 $556 $175–$1,930 $164
2025 $0 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $478,925 252 payments
  2. Pfizer Inc. $185,355 130 payments
  3. Sanofi US Services Inc. $750 4 payments
  4. Eisai Inc. $750 1 payment
  5. Penumbra, Inc. $173 2 payments
  6. Cook Medical LLC $101 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $665,780 387 payments
  2. Food and Beverage $274 5 payments
Products named General payments · program years 2019–2025
  1. KEYTRUDA $408,865 198 payments
  2. LORBRENA $80,395 35 payments
  3. LENVIMA $66,840 47 payments
  4. BAVENCIO $49,060 18 payments
  5. XTANDI $32,450 33 payments
  6. TALZENNA $16,640 29 payments
  7. IBRANCE $3,390 10 payments
  8. V937 $1,050 1 payment
  9. PRALUENT $750 4 payments
  10. Dayvigo $750 1 payment
  11. Other $447 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $105,670 20 payments
  2. Eli Lilly and Company $75,225 6 payments
  3. Regeneron Pharmaceuticals, Inc. $17,740 4 payments
  4. Epizyme, Inc., $2,775 2 payments
  5. Ipsen Innovation $75 1 payment

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$21,141

Medicare's payments for the services billed

Medicare patients

622

Average age 77

Services billed

840

357 women, 265 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 60%
Diabetes 48%
Heart failure 46%
Depression 45%
Chronic kidney disease 42%
COPD 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TALZENNA
  • PFIZER INC. $1,940
$1,940 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

425 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record